Systemic lupus erythematosus (SLE) is a progressive autoimmune disease characterized by increased sensitivity to self-antigens, auto-antibody production, and systemic inflammation. B cells have been implicated in disease progression and as such represent an attractive therapeutic target. Lyn is a Src family tyrosine kinase that plays a major role in regulating signaling pathways within B cells as well as other hematopoietic cells. Its role in initiating negative signaling cascades is especially critical as exemplified by Lyn-/- mice developing an SLE-like disease with plasma cell hyperplasia, underscoring the importance of tightly regulating signaling within B cells. This review highlights recent advances in our understanding of the function of the Src family tyrosine kinase Lyn in B lymphocytes and its contribution to positive and negative signaling pathways that are dysregulated in autoimmunity.
CITATION STYLE
Brodie, E. J., Infantino, S., Low, M. S. Y., & Tarlinton, D. M. (2018, March 1). Lyn, lupus, and (B) lymphocytes, a lesson on the critical balance of kinase signaling in immunity. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2018.00401
Mendeley helps you to discover research relevant for your work.